HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 42nd Annual.
For the two new Venice City Council members, it was rubber-meets-the-road time wslr.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wslr.org Daily Mail and Mail on Sunday newspapers.
Letter To The Editor: Thanking Christine Bernstein For Heartfelt Service ladailypost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ladailypost.com Daily Mail and Mail on Sunday newspapers.
– ARCALYST® Q3 2023 net product revenue of $64.8 million, representing ~94% year-over-year growth – – KPL-404 Phase 2 rheumatoid arthritis data from Cohorts 1-3 now expected in Q1.